EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Komrower Memorial Lecture 2023. Molecular basis of phenotype expression in homocystinuria: Where are we 30 years later?

Viktor Kožich iD, Tomas Majtan iD

Journal of Inherited Metabolic Disease · 2024

DOI: 10.1002/jimd.12767 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, 2024. Verfasst von Viktor Kožich und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, …. Hauptthemen laut MEDLINE: Homocystinuria, Cystathionine beta-Synthase, Phenotype. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of the Czech Republic, General University Hospital in Prague, Charles University, Cooperatio-Metabolic Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review summarises progress in the research of homocystinuria (HCU) in the past three decades. HCU due to cystathionine β‐synthase (CBS) was discovered in 1962, and Prof. Jan Peter Kraus summarised developments in the field in the first‐ever Komrower lecture in 1993. In the past three decades, significant advancements have been achieved in the biology of CBS, including gene organisation, tissue expression, 3D structures, and regulatory mechanisms. Renewed interest in CBS arose in the late 1990s when this enzyme was implicated in biogenesis of H 2 S. Advancements in genetic and biochemical techniques enabled the identification of several hundreds of pathogenic CBS variants and the misfolding of missense mutations as a common mechanism. Several cellular, invertebrate and murine HCU models allowed us to gain insights into functional and metabolic pathophysiology of the disease. Establishing the E‐HOD consortium and patient networks, HCU Network Australia and HCU Network America, offered new possibilities for acquiring clinical data in registries and data on patients' quality of life. A recent analysis of data from the E‐HOD registry showed that the clinical variability of HCU is broad, extending from severe childhood disease to milder (late) adulthood forms, which typically respond to pyridoxine. Pyridoxine responsiveness appears to be the key factor determining the clinical course of HCU. Increased awareness about HCU played a role in developing novel therapies, such as gene therapy, correction of misfolding by chaperones, removal of methionine from the gut and enzyme therapies that decrease homocysteine or methionine in the circulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HomocystinuriaCystathionine beta-SynthasePhenotypeHumansAnimalsMutationHistory, 21st Century

Stichwörter der Autor:innen

cystathionine β‐synthase deficiencydiagnosishistoryhomocystinuriaphenotypetreatment

Substanzen

Cystathionine beta-Synthase

Autor:innen und Institutionen

  • Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia.
  • Department of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.

ORCID-Profile: Viktor Kožich, Tomas Majtan

Förderung

  • Ministry of Health of the Czech Republic
  • General University Hospital in Prague
  • Charles University, Cooperatio-Metabolic Disorders
  • Travere Therapeutics
  • University of Fribourg
  • Swiss National Science Foundation
  • Ministerstvo Zdravotnictví Ceské Republiky
  • Všeobecná Fakultní Nemocnice v Praze

Zitieren

APA

Kožich, V., & Majtan, T. (2024). Komrower Memorial Lecture 2023. Molecular basis of phenotype expression in homocystinuria: Where are we 30 years later?. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12767

Vancouver

Kožich V, Majtan T. Komrower Memorial Lecture 2023. Molecular basis of phenotype expression in homocystinuria: Where are we 30 years later?. Journal of Inherited Metabolic Disease. 2024. doi:10.1002/jimd.12767

BibTeX
@article{Koich2024,
  author = {Kožich, Viktor and Majtan, Tomas},
  title = {Komrower Memorial Lecture 2023. Molecular basis of phenotype expression in homocystinuria: Where are we 30 years later?},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2024},
  doi = {10.1002/jimd.12767}
}
Kostenlos starten →